Kato H, Takata Y
Br J Pharmacol. 1987 Jan;90(1):191-201. doi: 10.1111/j.1476-5381.1987.tb16840.x.
We previously reported that verapamil, nicardipine and diltiazem inhibited both neurotransmitter release and contraction evoked by transmural nerve stimulation (TNS) in the canine saphenous vein. To evaluate whether the three Ca antagonists act on the nerve endings by inhibiting Ca2+ influx, the effects of the three antagonists were studied in the presence of 4-aminopyridine (4-AP) 3 X 10(-4) M on the TNS-evoked tritium overflow and contraction of canine saphenous veins preloaded with [3H]-noradrenaline. 4-AP increased both tritium overflow and contraction evoked by TNS, but did not enhance the contraction induced by exogenous noradrenaline (10 nmol). In the veins pretreated with 4-AP, verapamil (3 X 10(-5) M) and nicardipine (10(-5) M and 3 X 10(-5) M) caused no significant effects on the TNS-evoked tritium overflow, but they still inhibited the contraction. Diltiazem (10(-5) M and 3 X 10(-5) M) significantly inhibited both responses to TNS in the veins pretreated with 4-AP, the effects being nearly equipotent to those in the absence of 4-AP. The (-)-cis isomer of diltiazem (10(-5) M and 3 X 10(-5) M), which is about 100 times less potent than diltiazem in inhibiting Ca2+ influx, inhibited both responses to TNS in the presence of 4-AP to almost the same degree as diltiazem. When 4-AP was added after the Ca antagonists, it reversed the TNS-evoked tritium overflow inhibiting actions of verapamil (3 X 10(-5) M) and nicardipine (3 X 10(-5) M) much more effectively than that of diltiazem (3 X 10(-5) M). Tetracaine (4 X 10(-6) M) significantly inhibited the TNS-evoked tritium overflow and contraction, which were unaffected by 4-AP. Sodium salicylate (10(-2) M) failed to modify the inhibition of TNS-evoked tritium overflow following diltiazem (3 X 10(-5) M), but it enhanced that of tetracaine (4 X 10(-6) M). Verapamil but not diltiazem and nicardipine significantly increased the spontaneous tritium overflow from veins pretreated with 4-AP. The present study together with previous results suggests that diltiazem but not verapamil and nicardipine may inhibit the TNS-evoked neurotransmitter release through an action other than inhibition of Ca2+ influx into the adrenergic nerve endings, allowing an inhibition of the resulting contraction.
我们先前报道过,维拉帕米、尼卡地平与地尔硫䓬可抑制犬隐静脉经壁神经刺激(TNS)诱发的神经递质释放与收缩。为评估这三种钙拮抗剂是否通过抑制Ca2+内流作用于神经末梢,我们研究了在3×10(-4)M 4-氨基吡啶(4-AP)存在的情况下,这三种拮抗剂对预先用[3H]-去甲肾上腺素负载的犬隐静脉TNS诱发的氚溢出及收缩的影响。4-AP可增加TNS诱发的氚溢出及收缩,但不会增强外源性去甲肾上腺素(10 nmol)诱发的收缩。在用4-AP预处理的静脉中,维拉帕米(3×10(-5)M)和尼卡地平(10(-5)M与3×10(-5)M)对TNS诱发的氚溢出无显著影响,但它们仍可抑制收缩。地尔硫䓬(10(-5)M与3×10(-5)M)可显著抑制用4-AP预处理的静脉对TNS的两种反应,其作用与不存在4-AP时几乎相当。地尔硫䓬的(-)-顺式异构体(10(-5)M与3×10(-5)M)在抑制Ca2+内流方面的效力比地尔硫䓬低约100倍,在4-AP存在的情况下,其对TNS两种反应的抑制程度与地尔硫䓬几乎相同。当在钙拮抗剂之后加入4-AP时,它逆转维拉帕米(3×10(-5)M)和尼卡地平(3×10(-5)M)对TNS诱发的氚溢出的抑制作用比逆转地尔硫䓬(3×10(-5)M)的作用更有效。丁卡因(4×10(-6)M)可显著抑制TNS诱发的氚溢出及收缩,而4-AP对此无影响。水杨酸钠(10(-2)M)未能改变地尔硫䓬(3×10(-5)M)对TNS诱发的氚溢出的抑制作用,但增强了丁卡因(4×10(-6)M)的抑制作用。维拉帕米可显著增加用4-AP预处理的静脉的自发性氚溢出,而地尔硫䓬和尼卡地平则无此作用。本研究与先前结果共同表明,地尔硫䓬而非维拉帕米和尼卡地平可能通过抑制Ca2+流入肾上腺素能神经末梢以外的作用来抑制TNS诱发的神经递质释放,从而抑制由此产生的收缩。